Tackling High-Cost Specialty Drugs and Preserving Patient Centered Innovation (Webinar)
ACHP examines how organizations are managing high-cost specialty drugs to ensure patients get the drugs they need without breaking the bank.
Tag: generic drugs /biosimilars
Lowering Drug Costs through Transparency and Competition
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation.
Curbing High Drug Costs
ACHP’s bipartisan policy recommendations will help hold drug makers accountable and curb exorbitantly high drug costs.
Community Health Plans Are Serious: Support Major Federal Action to Reduce Prescription Drug Costs
ACHP backs concrete efforts by the federal government to reign in high drug costs, such as empowering Medicare negotiations.
Complete the Journey from Volume to Value
This issue brief outlines how a shift to value-based care can improve health outcomes, lower costs and improve patient satisfaction.
